The etiology ofsensorineural hearin g loss (SNHL) associated with renal failure and hemodialysis is controversial. Possible mechanisms include a shared antigenicity between the kidn ey and the labyrinths. osmotic alteration caused by hemodialysis, and the ototoxic effect of diuretics. We present 2 cases of SNHL associat ed with renal failure and its treatm ent. One patient was a 35-year-old man who developed prof ound SNHL aft er 5 sessions of hemodialysi s. and the othe r was a 36-year-old woman who developed severe to profound SNHL after 7 sess ions. It is our impress ion that both hearin g losses might have been attributabl e to osmo tic disequilibrium in the labyr inth or to an acut e labyrinthine inju ry caused by contamination of the blood by the degraded p roduct of an old cellulose acetate hemodialyzer membrane; the hemodialyzer had been in use f or 15 years.
Introduction
Sudden sensorineural hearing loss (SNHL) is frequently reported in patients with renal failure who undergo hemodialysis, but its etiology in thi s circumstance remains controversiaL I One pos sible explanation is that the kidney and the labyrinths have a shared antigenicity and , as a result , many pati ent s with con genital ren al failure have SNHL. In addition, many nephrotoxic dru gs are also ototo xic." Moreover, a sig nifica nt decrease in cochlear microphonic and coc hlea r nerve action potenti al has been demonstr ated in guinea pig s in a uremi c state.' Thi s finding has been corr oborated in hum ans; lengthenin g of the interpeak latencies in the auditory brain stem response , collapse of the endo lymphatic space, and the presence of deposits in the stria and vestibular apparatus have been document ed in uremic humans.' Hemodialysis also appear s to have an ototoxic effect, although in some case s it is difficult to make a sharp distinction between its effects and the effects of the renal failure itself. The prev alence of hearin g loss in hemodialysis-treated patients has been rep orted to range betw een 15 and 54%. 1-6
An osmotic/electrolytic alterat ion cau sed by hemodialys is ca n result in ( I) a loss of outer hair cells and spira l ga nglion in the cochlea, (2) coll apse of the endolymphatic space, and (3) edema and atrophy of th e specialized auditory cells." ?Also, the etiology of deafness in these patients may be related to the prem ature agin g induced by ch roni c renal failure. Fin ally, hearin g loss might be cau sed by co ntamination of the blood by remn ant s of old dialysi s material , particularly cellul ose ace tate.
Our dialy sis center at Univ ersity Coll ege Hospital in Ibadan , Nigeria wa s establi shed approximately 15 yea rs ago. Since then, we have dialyzed more than 1,000 patients. In thi s article, we report 2 cases of SNHL that occurred during the course of dialy sis. We believe these hearing losses were probably caused by contamination of the blood by the degraded product of an old cellulose acetate hemodialyzer membrane . We also review the literature on hearing loss and renal failure.
Case reports
Pati ent 1. A 35-year-old man, a baker and teacher, was admitted via the accident and emergency unit with a 2-week history of diarrhea and vomiting . He had been pre viously seen at a pri vate hospit al, where he had been receiving treatm ent for oliguria, an altered level of consciou sness, and a biochemical profile consistent with renal failure. He had no histo ry of kidney disea se or ex po sure to nephrotoxic substances, and no history of facial or pedal edema. Compl ete details on the dru gs that had been adm iniste red at the pri vate hospit al were una vailable.
On examination, the patient was confused, dro wsy, pale, anicteric, afebrile, and dehydrated . Facial swelling and mild pedal edema were present. On admission, he had an elevated blood pressure (\ 50/80 mm Hg), serum urea nitrogen level (347 mg/dl) , and creatinine level (12 .5 mg/dl) and a low hematocrit ( 11%). Findings in other systems were esse ntially normal. A diagnosis of acute renal failure secon dary to gastroenteritis was made, and he was prescribed dialysis.
After the fifth session ofhemodialysis, the patient had experienced some clinical improvement, but he discovered that he was unable to hear. He was able to speak coheren tly and understand and reply to written messages and instructions. He was referred to the consultantotorhinolaryngologist, who found that the patient could not hear normal conversation at 1 meter. At closer proxi mity, he could barely hear a shout, and he was not able to recog nize speec h.
An ENT examination revealed normal anatomy. The patient exhibited no response to tunin g-fork testing. Puretone audiometry at 500 to 8,000 Hz revealed a profound bilateral hearing loss. Bone conduction was less than 100 dB and air conduction was 90 dB. Findi ngs on repea t audiometry 3 month s later were unchanged, and the patient' s speech recog nition was poor. He was advised to procure a set of hearing aids. Audiometric findings at 6 months were unchanged.
Patient 2. A 36-year-o ld woman, a trader, was referred to the medical outpatient unit of a private hospital by her private physician with a 2-day history of generalized malaise, dizziness, vomiting, and early-morning facia l puffiness. She had been diagnosed with hypertension 3 years earlier, but her blood pressure was not well controlled. She had experienced 2 episodes of spontaneous abortio n, one 4 years earlier and the other the previous year; retained products had been removed by vacuum aspiratio n and dilation and curettage . She had a history of using oral contrace ptives and abusing topical steroids for skin toning. Examin ation revea led that her blood pressure ( 170/100 mm Hg), serum urea nitrogen level (2 12 mg/dl), and crea tinine level (26.3 mg/dl) were high and her hem atocrit was low (15%). Other systems were esse ntially normal. The patient was diagnosed with chronic renal failure secondary to hypertensive nephrosclerosis and prescribed hemodialysis and blood transfusions. After 4 sessions of hemodialysis and transfusion of 4 pints of blood, the patient demonstrated clinical imp rovement. Her serum urea nitrogen level fell to 50 mg/dl, and her creat inine level dropped to 5.5 mg/dl. She was discharged home on antihypertensive and diuretic medications.
During follow -up at our outpa tient clinic, we found that the patient's biochemical profile had deteriorated. She was placed on alternate-week main tenance dialysis because she could not afford regular dia lysis. She also received additional blood transfusions to treat severe anemia. After the seve nth sess ion of hemodialysis, the patient complained of hearing loss. The hearing loss progressed rapidly, and within 3 weeks she had beco me deaf.
An exami nation revealed that the external anatomy of the ear, nose, and throat was normal. The patient exhibited no respo nse to tunin g-fork testing or to distraction testing 820 with a bell rung at ear level. Pure-tone aud iometry revealed a profound bilateral bone-conduction hearing loss (<100 dB at all frequencies). The patient was adv ised to procure a set of hearing aids. She was lost to follow-up.
Discussion
Hemodialysis has remarkably improved the prognosis for patients with chronic renal disease, but many com plain of tinnitus, vertigo, and hearing loss." The results of several investiga tions have suggested that permanent SNHL develops in as many as 54% of patients with nonhereditary chronic renal failure; the vast majority of affec ted patient s had been treated with hemodialysis.!" ada et al reported hearing loss in 43 of290 hemodialysis patients (15%).5 Their temporal bone studies showed that cochlear changes ranged from a mild loss of outer hair cells in patients who had undergone relatively few hemodialysis treatments and transplants to a comp lete absence ofthe organ of Corti in patients who underwent more than 250 hemodialysis treatme nts and multiple transplants. They concluded that the severity ofthe clinical and histopathologic findings was direct ly proportional to the number of hemodialysis treatments and transpla nts patients underwent.
Kligerman et al found high-freq uency (>2,000 Hz) hearing loss in 15 of28 patients (54%) treated with hemodialysis.' The site of the lesion was the coc hlea . They reported an associa tion betwee n hearing loss and the duration of hemodialysis; hearing losses occ urred in 30% of patients who had been on hemodialysis for 18 months or less and in 67% of those who had been on hemodialysis for more than 18 months. Hearing loss was also assoc iated with the duration of individu al hemodialysis sess ions. Age, noise exposure, and drug ototoxicity did not contribute to hearin g loss in this study.
Bergstrom et al reported that 9 1of224 patients (4 1%) with chronic renal disease treated with hemodialysis developed SNHL. 6E xam ination of the temporal bone revealed fibrous tissue in perilymph atic spaces and degradation of the organ of Corti in one of these patie nts and a loss of hair cells of the organ of Corti in some others . The authors suggested that the strial deposits were calc ific and possibly formed as a result of abno rma l calci um-phosphorus metabolism.
Johnson and Mathog studied 61 patie nts with chro nic rena l failure undergoing hemod ialysis and reported a significant high-frequency deficit early in the course of hemodialysis." Th ey also found fluctuatio ns in hearing during single dialysis events ; these fluctuations were transient and inde pendent of changes in levels of sodium, potassi um, ca lcium, blood urea nitrogen, glucose, blood pressure, and weight. The auditory depression reported occurred above 2 kHz.
Several other isolated cases have been reported. Rizvi and Holmes describ ed the case of a 47-yea r-old man with chronic renal fai lure and normal hearing who experienced hearing loss in "a dditive increments" durin g peritoneal dialy sis and hemodi alysis until he became profoundly deaf in both ears.? Postmortem studies revealed a collapse of his endolymphatic system and the presence of edem a and atrophy in most of the specialized cell types of the auditory and vestibular sensory organs. The authors proposed that these alterations were caused by osmotic disequ ilibrium associated with hemodialysis. A similar conclusion was reached by Makita et al. ' ?
Hutter et al observed acute-onset hearing loss and severe neurologic symptoms 7 to 24 hours after hemodialysis in 7 hospitalized patients. I I Th is finding drew attention to the issue of the long-term integrity of dialysis machines and materials. The authors concluded that these injuries were associated with exposure to aged cellulose acetate dialyzer membranes, which allowed cellu lose acetate degr adation products to enter the bloodstream.
Many others have reported the ototoxic effect of hexad imethrine bromide (Polybrene) and other macromolecular substances.l-P 'Iemporal bone examination showed severe losses of hair cells in the organ of Corti following hexadimethrine administration.
Others have found that SNHL was not related to hemodia ysis . Ozturan and Lam studied 15patients and 10controls and compared pure-tone audiometry and distortion -product otoacoustic emissions (DPOAE) measurements before and after hemodialysis." They found no difference in the pure -tone average before and after hemodialysis. They concluded that hemodialysis is safe and that the SNHL in these patients may have been attributable solely to their renal disease. Stavroulaki et al studied the effect of hemodialysis on hearing acuity in 9 children with end-stage renal disea se." They found SNHL of unknown etiology in 5 of these patients (56 %) on pure-tone audiometry and DPOAE measurements.They concluded that high-frequency SNHL is common in young renal failure patients who undergo multiple hemodialysis but that a single hemodialysis session doe s not appear to alter their hearing acuity.
Kusakari et al analyzed the hearing of 37 hemodialysis patients .16Hearing evalu ations were performed at the initiation of hemodialysis and every 3 to 12 months there after for at least 4 years . Only 3 patients exhibited sign ificant hearin g loss after hemodialysis. The authors concluded that hemodialysis per se does not harm the cochlea and that hearing can be maintained at pre-hemodialysis levels in most pat ients.
Deafne ss may be reversible in some patients with chronic renal failure who undergo hemodialysis, so a prolonged follo w-up is necessary.
In our 2 patient s, a profound, sudden-onset SNHL devel oped during the course of hemodi alysis, and it was confirmed by pure-t one audiometry. The hearing loss was evident at all frequencies, unlike the case in many other reports, in which hearing loss was limited to the high frequencies. Althou gh authors have reported the superiority Volume 85, Number 12 of DPOAE measurements over pure-tone audiometry for the detection of earl y hearing loss, the latter is still reliable.9.'4. '5 It is our interpretation that the hearing loss in our 2 patient s can be explained by (1) an acute osmotic imbalance caused by hemodialysis or (2) an acute labyrinthine injury secondary to the introduction into the bloodstream of degraded product from an old cellulose acetate membrane in a hemodialyzer that had been in use for 15 years.
In conclusion, hearing loss is a common finding in patient s with chronic renal failure , and deafness may occur during the course of hemodialysis. Uremia, ototo xins, axonal uremic neuropathy, anemi a, and toxic degrad ation products from cellulose acetate dialyzer membranes are all possible etiologic factors . We hope that a prospective study on this subject may clarify the relationship between hearing loss and chronic renal failure and its treatment.
